Brief: Allena Pharma Reports Q2 Loss Per Share Of $0.26
05/08/2020 13:31
Aug 5 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.26
* Q2 EARNINGS PER SHARE ESTIMATE $-0.30 -- REFINITIV IBES
DATA
* ALLENA PHARMACEUTICALS - EXPECTS CASH EQUIVALENTS WILL BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURE
REQUIREMENTS BEYOND Q2 OF 2021
Source text for Eikon: ID:nGNX2xHwXZ
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing